Panagora Asset Management
CASI icon

Panagora Asset Management’s CASI Pharmaceuticals CASI Stock Holding History

Panagora Asset Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-155
Closed -$2K – 1814
2021
Q2 		$2K Sell
155
-12,420
-99% -$209K ﹤0.01% 2621
2021
Q1 		$302K Buy
+12,575
New +$353K ﹤0.01% 1564

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Panagora Asset Management's CASI Position: Q3 2021 in Review

Panagora Asset Management sold out of CASI Pharmaceuticals (CASI) in Q3 2021, closing a stake of 155 shares — an estimated $2K sold.

Panagora Asset Management first reported a position in CASI in Q1 2021 and held it in 2 quarters. The position peaked at $302K in Q1 2021. 58 funds tracked by Wall St. Rank hold CASI as of Q3 2021.

  • Panagora Asset Management reported no remaining CASI Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 155 CASI Pharmaceuticals shares in Q3 2021, an estimated $2K.
  • Panagora Asset Management first reported a position in CASI Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • Panagora Asset Management's CASI Pharmaceuticals position peaked at $302K in Q1 2021.
  • 58 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.